関連する実験動画

Updated: May 10, 2026

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

27.5K

ペリトネアルメソテリオマに対する第一線カルボプラチン,ペメトレクセド,ベバシズマブの成功反応: 2件の症例報告

Tomonobu Koizumi1,2, Shintaro Kanda2, Nodoka Sekiguchi2

  • 1Department of Medicine, Nagano Prefectural Kiso Hospital, Nagano, Japan.

Case reports in oncology
|August 29, 2025
PubMed
まとめ

二人の腹膜内皮腫患者は,カルボプラチン,ペメトレクセド,ベバシズマブによる化学療法により,長期生存と完全応答を達成しました. この組み合わせ治療は この珍しい癌の治療に 有望な結果を示しています

キーワード:
血管新生完全な応答維持療法整体化学療法VEGF について

さらに関連する動画

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

10.6K
Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines08:01

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines

Published on: April 21, 2022

2.0K

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...